Dr. G. Papaccio
Institute of Anatomy School of Medicine II University of Naples via L. Armanni, 5 
1-80138 Naples Italy
Response from the authors Dear Sir, We read with great interest the comments made by Pappaccio and Chieffi Baccari. As we did not have the benefit of the authors' recent or unpublished results at the time, we indeed suggested in our manuscript that the vascular alterations noted in streptozotocin-treated animals might be a consequence of the often extensive islet inflammarion caused by this beta-toxic agent [1] . Recent findings, however, shed more light on the chronology of histologic changes witnessed in low-dose streptozotocin-induced diabetes [2, 3] .
The early stages of disease of the two animal models of human Type 1 (insulin-dependent) diabetes mellitus under discussion -the spontaneously diabetic BioBreeding rat and the low-dose streptozotocin-treated mouse -seem to have many features in common. In both models, macrophage infiltration of the islets is one of the earliest, and presumably essential events in the course of the disease which occurs prior to the development of insulitis and/or beta-cell damage [2, 4] . Furthermore, around that same time the microvasculature in and around the pancreatic islets in both animals undergoes various alterations, such as vasoconstriction ( [3] , streptozotocin) and increased vascular permeability ( [1] , BB).
In our report [1] , which is to be seen primarily as the introduction of a novel, high resolution method with which to study the islet microvasculature, we did not elaborate on the possible mechanisms of the observed increase in vascular permeability in pre-diabetic BB rats. Although conclusive evidence is lacking, several observations made during this study suggest, however, the existence of a functional relationship between the islet microvasculature and macrophages in the early stage of disease. In the pre-diabetic BB rats mononuclear phagocytes were frequently observed within the microvasculature and parenchyma of the islets and the surrounding acinar tissue. In extravascular locations, the mononuclear cells often displayed the ultrastructural features of activated macrophages (cellular protrusions, expanded endoplasmic reticulum, endocytic vesicles and a large euchromatic nucleus). With pre-embedding immunostaining, we were able to demonstrate strong immunoreactivity for Ia (class II MHC) antigens on macrophages in the acinar tissue surrounding the islets, which again reflects the state of activation of the macrophages. Finally, the vascular leakage was most prominent in the post-capillary venules, site of action of vasoactive monokines.
The microvascular changes observed early in the disease process may have important clinical implications. Indeed, it has been demonstrated that administration of serotonin and histamine inhibitors suppresses the development of diabetes in low-dose streptozotocintreated mice [5] . These and other findings suggest the role of the pancreatic microvasculature, and possibly its interaction with mononuclear phagocytes, in the pathogenesis of diabetes, and we hope that our contribution may prove useful for further investigations in this field.
Yours 
Follow-up of anti-beta-lactoglobulin antibodies in children with Type 1 (insulin-dependent) diabetes meHitus
Dear Sir, Recently Dahlquist et al. [1] reported that early exposure to cow's milk formula is related to an increased risk of early-onset Type 1 (insulin-dependent) diabetes mellitus. The authors found increased beta-lactoglobulin IgA antibodies and cow's milk protein IgA antibodies in children with early-onset Type I diabetes and suggest that early exposure to beta-lactoglobulin in genetically susceptible children might be one trigger in the autoimmune process leading to development of Type i diabetes. We studied 26 children (14 males and 12 females) aged 1.4-16.2 years, with recently-diagnosed Type 1 diabetes followed-up for 2-5 years. Nine patients had been breastfed and 17 bottle-fed. In all patients we evaluated IgA and IgG antibodies to beta-lactoglobulin by ELISA. The control group comprised 59 healthy age-and sex-matched subjects. At diagnosis, 13 patients (50%) had elevated beta-lactoglobulin IgA ( > + 2SD) and 2 (7.7%) elevated beta-lactoglobulin IgG antibodies (> + 2SD). ICA were present in 19 of 26 (73 %) and anti-insulin antibodies in 6 of 26 (23 %) patients.
Over the 2-5-year follow-up we observed a transient increase in beta-lactoglobulin IgA antibodies in two other patients. At the end of follow-up beta-lactoglobulin IgA antibodies decreased to normal levels in all but two females ( Fig. 1 ) and beta-lactoglobulin IgG antibodies in all patients. No correlation was found between beta-lactoglobulin IgA or IgG antibodies and age, breast-feeding duration, islet-cell, anti-insulin or other organ and non-organ specific antibodies and HLA types. No difference was found in beta-lactoglobulin antibody levels between breast-or bottle-fed patients.
Some investigators have suggested that breast-feeding may protect against the risk of Type 1 diabetes in later life [2] [3] [4] , but the results of more recent studies are conflicting [5] . It has been hypothesized that intestinal permeability is increased in Type I diabetes [6] . On the other hand a strong antigenic similarity has been observed between human beta-casein and bovine beta-lactoglobulin [7] and the presence in human milk of beta-lactoglobulin from cow's milk in the mother's diet has been confirmed [8] . These observations together with our findings that anti-beta-lactoglobulin antibodies tend to disappear during follow-up, suggest that they represent only a transient abnormal immunological response. These antibodies may reflect increased production of antibodies against different antigens by B-lymphocyte clones [9] .
Yours sincerely, R. Lorini, M. A. Avanzini and L. Vitali l~g.1. Beta-lactoglobulin IgA antibody (IgA-ab) levels in 26 children with Type 1 diabetes at diagnosis and during 2-5-year followup. 9 ICA-positive patients; 9 ICA-negative patients; $ the two patients with elevated beta-lactoglobulin IgA-antibody levels at the end of the follow-up. The line at 75 % indicates 2SD
